On the clinical side, the PNP inhibitor forodesine is currently in a variety of clinical trials as a possible treatment for lymphomas (https://www.clinicaltrials.gov/ct2/results?term=Forodesine&flds=Xabce). Here, PNP is linked to lymphoma.